Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes

Winston A. Haynes, Kathy Kamath, Carolina Lucas, John Shon, Akiko Iwasaki
doi: https://doi.org/10.1101/2021.01.06.20248960

Article Information

doi 
https://doi.org/10.1101/2021.01.06.20248960
History 
  • January 8, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Winston A. Haynes1,
  2. Kathy Kamath1,
  3. Carolina Lucas2,
  4. John Shon1,* and
  5. Akiko Iwasaki2,3,*
  1. 1Serimmune, Inc., Goleta, CA, USA
  2. 2Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  3. 3Howard Hughes Medical Institute, Chevy Chase, MD, USA
  1. ↵*Co-corresponding authors; email: john.shon{at}serimmune.com
Back to top
Posted January 08, 2021.
Download PDF
Data/Code
Email
Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes
Winston A. Haynes, Kathy Kamath, Carolina Lucas, John Shon, Akiko Iwasaki
medRxiv 2021.01.06.20248960; doi: https://doi.org/10.1101/2021.01.06.20248960
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area